Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Net Income (2016 - 2025)

Historic Net Income for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to -$4.1 million.

  • Traws Pharma's Net Income rose 5249.53% to -$4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.8 million, marking a year-over-year increase of 8884.91%. This contributed to the annual value of -$142.4 million for FY2024, which is 60141.89% down from last year.
  • Latest data reveals that Traws Pharma reported Net Income of -$4.1 million as of Q3 2025, which was up 5249.53% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Net Income registered a high of -$1.2 million during Q2 2025, and its lowest value of -$123.3 million during Q2 2024.
  • Moreover, its 5-year median value for Net Income was -$4.6 million (2021), whereas its average is -$11.0 million.
  • Per our database at Business Quant, Traws Pharma's Net Income plummeted by 257566.16% in 2024 and then skyrocketed by 9898.74% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's Net Income stood at -$3.8 million in 2021, then tumbled by 52.38% to -$5.7 million in 2022, then increased by 22.18% to -$4.5 million in 2023, then dropped by 18.29% to -$5.3 million in 2024, then grew by 23.17% to -$4.1 million in 2025.
  • Its Net Income stands at -$4.1 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$5.2 million for Q1 2025.